Michael D Kishbauch - Net Worth and Insider Trading
Michael D Kishbauch Net Worth
The estimated net worth of Michael D Kishbauch is at least $0 dollars as of 2024-05-12. Michael D Kishbauch is the Director of Achillion Pharmaceuticals Inc and owns about 0 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $0. Details can be seen in Michael D Kishbauch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael D Kishbauch has not made any transactions after 2014-08-15 and currently still holds the listed stock(s).
Transaction Summary of Michael D Kishbauch
Michael D Kishbauch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael D Kishbauch owns 5 companies in total, including Astria Therapeutics Inc (ATXS) , Achillion Pharmaceuticals Inc (ACHN) , and Progenics Pharmaceuticals Inc (PGNX) among others .
Click here to see the complete history of Michael D Kishbauch’s form 4 insider trades.
Insider Ownership Summary of Michael D Kishbauch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATXS | Astria Therapeutics Inc | 2016-04-05 | director |
| ACHN | Achillion Pharmaceuticals Inc | 2020-01-28 | director |
| PGNX | Progenics Pharmaceuticals Inc | 2019-07-11 | director |
 | | 2015-01-28 | director |
| | 2008-01-18 | director |
Michael D Kishbauch Latest Holdings Summary
Michael D Kishbauch currently owns a total of 1 stock. Michael D Kishbauch owns 0 shares of Achillion Pharmaceuticals Inc (ACHN) as of August 15, 2014, with a value of $0.
Latest Holdings of Michael D Kishbauch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACHN | Achillion Pharmaceuticals Inc | 2014-08-15 | 0 | 6.76 | 0 |
Holding Weightings of Michael D Kishbauch
Michael D Kishbauch Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael D Kishbauch has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 495,812 shares on August 15, 2014, which brought Michael D Kishbauch around $5 Million.
Insider Trading History of Michael D Kishbauch
- 1
Michael D Kishbauch Trading Performance
Michael D Kishbauch Ownership Network
Michael D Kishbauch Owned Company Details
What does Astria Therapeutics Inc do?
Who are the key executives at Astria Therapeutics Inc?
Michael D Kishbauch is the director of Astria Therapeutics Inc. Other key executives at Astria Therapeutics Inc include Chief Medical Officer Christopher Morabito , director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Chief Business Officer Andrea Matthews .
Astria Therapeutics Inc (ATXS) Insider Trades Summary
Over the past 18 months, Michael D Kishbauch made no insider transaction in Astria Therapeutics Inc (ATXS). Other recent insider transactions involving Astria Therapeutics Inc (ATXS) include a net purchase of 5,204,223 shares made by Perceptive Life Sciences Master Fund Ltd , and a net sale of 20,000 shares made by Christopher Morabito .
In summary, during the past 3 months, insiders sold 10,000 shares of Astria Therapeutics Inc (ATXS) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 20,000 shares of Astria Therapeutics Inc (ATXS) were sold and 5,204,223 shares were bought by its insiders, resulting in a net purchase of 5,184,223 shares.
Astria Therapeutics Inc (ATXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Astria Therapeutics Inc Insider Transactions
Michael D Kishbauch Mailing Address
Above is the net worth, insider trading, and ownership report for Michael D Kishbauch. You might contact Michael D Kishbauch via mailing address: 18 Cherryville Rd, Flemington Nj 08822.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
